Stay updated on Pembrolizumab After Weekly Paclitaxel Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.

Latest updates to the Pembrolizumab After Weekly Paclitaxel Clinical Trial page
- Check3 days agoChange DetectedThe study record now shows 'Results Submitted' instead of 'No Results Posted'.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This reflects a site version update and does not modify study content.SummaryDifference0.1%

- Check53 days agoChange DetectedFallopian Tube Cancer was added to the conditions list and a new Resources section with the Genetic and Rare Diseases Information Center was added. The page footer now shows Revision: v3.4.2.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now shows a revision update from v3.4.0 to v3.4.1 with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedGlossary display was added, and metadata related to QC updates was added (Last Update Submitted that Met QC Criteria) along with Revision: v3.4.0. The older QC label variant, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab After Weekly Paclitaxel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.